This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: The Rockefeller University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: A James Hudspeth: Innovator in Cellular Proliferation and Hearing Loss Treatment
Introduction: A James Hudspeth is a notable inventor based in New York, NY (US). He is affiliated with The Rockefeller University, where he contributes to advancements in cellular proliferation and hearing loss treatment. Although he currently holds no granted patents, his work is significant in the field of biomedical research.
Latest Patent Applications: A James Hudspeth has submitted several patent applications, including "Pyrrolopyridine-3- and 4-Carboxamide Compositions and Methods for Cellular Proliferation." This application focuses on compounds such as N-(3-substituted thiazaheterocyclylidene)-1H-pyrrolo[2,3-b]pyridine-3-carboxamides and N-(3-substituted thiazaheterocyclylidene)-1H-pyrrolo[2,3-b]pyridine-4-carboxamides. Another application is titled "Pyrrolo[2,3-b]pyridine-3-Carboxamide Compositions and Methods for Ameliorating Hearing Loss," which discloses compounds that activate Yap and inhibit Lats kinases, making them useful for treating hearing loss.
Conclusion: A James Hudspeth is an influential figure in the realm of biomedical innovation, focusing on cellular proliferation and hearing loss. His ongoing research and patent applications reflect his commitment to advancing medical science.